HLA-B and cardiomyopathy: At level 3, the HL group showed lower abundance in various pathways but higher in “RNA transport,” while the HLB group showed higher abundance in several pathways, including gastric acid secretion and cardiomyopathy-related pathways, and the HLAB group showed higher enrichment in biosynthesis and signaling pathways.